Romidepsin and Abraxane in Treating Patients With Metastatic Inflammatory Breast Cancer

Clinical trial NCT01938833 · TERMINATED

Trial details

NCT number: NCT01938833
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University
Status: TERMINATED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

HER2-negative Breast Cancer Inflammatory Breast Cancer Male Breast Cancer Recurrent Breast Cancer Stage IV Breast Cancer

Start date: 2014-04-01
Primary completion: 2016-08-18
Enrollment: 9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.